News

bit.bio receives £40m of backing for technology that it claims can reliably reprogram stem cells.

bit.bio joins forces with London institute of mathematical sciences to find the ‘operating system of life’.

Mark Kotter Bit Bio ideaSpace, focus on a founder, celebrating 10 years of idea space.

The investors behind Bit Bio's series A fundraise.

Bit Bio raises series A funding for its programming approach to human cells.

Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.

bit.bio closes series A $41.5 million funding.

Bit Bio announces agreement with Abcam, to make Bit Bio’s iPSC derived functional human cells widely available.